香港大學婦產科 HKU O&G

11/09/2026

✨ 𝓕𝓻𝓮𝓮 𝓟𝓻𝓸𝓯𝓮𝓼𝓼𝓲𝓸𝓷𝓪𝓵 𝓛𝓮𝓬𝓽𝓾𝓻𝓮 ✨

Cervical cancer remains a major public‑health challenge across the Asia‑Oceania region, particularly within low‑ and middle‑income countries. While cervical cancer is highly preventable, inequities in access to HPV vaccination and screening services continue to persist.

We are pleased to invite you to an insightful session delivered by 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐨𝐫 𝐃𝐞𝐛𝐨𝐫𝐚𝐡 𝐁𝐚𝐭𝐞𝐬𝐨𝐧. During this lecture, Professor Bateson will review existing progress, share inspiring case studies from Australia and New Zealand, and discuss core strategies to accelerate regional efforts towards cervical‑cancer elimination. Participants will gain insights into how cross‑sector collaborations, innovative interventions and strengthened health‑system capacity can drive meaningful transformative impact.

📢 Lecture Title: 𝐄𝐥𝐢𝐦𝐢𝐧𝐚𝐭𝐢𝐧𝐠 𝐂𝐞𝐫𝐯𝐢𝐜𝐚𝐥 𝐂𝐚𝐧𝐜𝐞𝐫 𝐢𝐧 𝐀𝐬𝐢𝐚-𝐎𝐜𝐞𝐚𝐧𝐢𝐚: 𝐖𝐨𝐫𝐤 𝐃𝐨𝐧𝐞 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐖𝐚𝐲 𝐅𝐨𝐫𝐰𝐚𝐫𝐝

📅 Date: 23 September 2026 (Wednesday)
🕐 Time: 5:30 p.m. - 6:30 p.m.
🖥️ Format: Hybrid Mode: Lecture Theatre, 6/F, Professorial Block, Queen Mary Hospital / Online via Zoom

𝐃𝐨𝐧’𝐭 𝐦𝐢𝐬𝐬 𝐭𝐡𝐢𝐬 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐭𝐨 𝐠𝐚𝐢𝐧 𝐯𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧𝐭𝐨 𝐚𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐡𝐞𝐚𝐥𝐭𝐡 𝐞𝐪𝐮𝐢𝐭𝐲 𝐚𝐧𝐝 𝐩𝐫𝐨𝐠𝐫𝐞𝐬𝐬𝐢𝐧𝐠 𝐭𝐨𝐰𝐚𝐫𝐝 𝐚 𝐰𝐨𝐫𝐥𝐝 𝐟𝐫𝐞𝐞 𝐟𝐫𝐨𝐦 𝐜𝐞𝐫𝐯𝐢𝐜𝐚𝐥 𝐜𝐚𝐧𝐜𝐞𝐫 — 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐍𝐎𝐖: https://forms.cloud.microsoft/r/gxh8tbnU5X

10/09/2026

📢 【 𝑳𝑨𝑺𝑻 𝑪𝑨𝑳𝑳 | 𝑨𝒃𝒔𝒕𝒓𝒂𝒄𝒕 𝑺𝒖𝒃𝒎𝒊𝒔𝒔𝒊𝒐𝒏 】

🕛‼️ 𝐒𝐮𝐛𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 𝐓𝐨𝐧𝐢𝐠𝐡𝐭, 𝟐𝟑:𝟓𝟗 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐓𝐢𝐦𝐞 (𝐔𝐓𝐂/𝐆𝐌𝐓 +𝟖)

🗓️ 13–14 October 2026 (Tuesday and Wednesday)
📍 HKUMed Faculty Boardroom, The University of Hong Kong

This workshop brings together clinician-scientists, researchers, and healthcare professionals dedicated to advancing maternal metabolic health and optimising care for women living with Gestational Diabetes Mellitus (GDM).

Selected abstracts will be featured as 𝐞-𝐩𝐨𝐬𝐭𝐞𝐫 𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧𝐬 — a great opportunity to showcase your research and connect with experts across the Asia-Pacific region and beyond.

📝✨ 𝐒𝐮𝐛𝐦𝐢𝐭 𝐍𝐎𝐖 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐀𝐛𝐬𝐭𝐫𝐚𝐜𝐭 𝐒𝐮𝐛𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐏𝐨𝐫𝐭𝐚𝐥: https://gdmapac.org/call-for-e-poster-abstracts.html — don't let this opportunity pass you by!

💬 Enquiries: +852 2559 9973 | [email protected]

Let's build a strong, inclusive, and sustainable research network together. See you in Hong Kong this October!

10/09/2026

📢 【 𝑭𝑰𝑵𝑨𝑳 𝑹𝑬𝑴𝑰𝑵𝑫𝑬𝑹 | 𝑨𝒃𝒔𝒕𝒓𝒂𝒄𝒕 𝑺𝒖𝒃𝒎𝒊𝒔𝒔𝒊𝒐𝒏 】

🕛‼️ This is it — the 𝐄𝐱𝐭𝐞𝐧𝐝𝐞𝐝 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞 is 𝐓𝐎𝐌𝐎𝐑𝐑𝐎𝐖, 𝟏𝟏 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟔 (𝐅𝐫𝐢𝐝𝐚𝐲), 𝟐𝟑:𝟓𝟗 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐓𝐢𝐦𝐞 (𝐔𝐓𝐂/𝐆𝐌𝐓 +𝟖)!

We cordially invite researchers, clinicians, scholars and industry practitioners across the globe to submit abstracts for e-poster presentation. The symposium welcomes abstracts covering all frontier and interdisciplinary domains of reproductive medicine and assisted reproduction.

📝✨ 𝐒𝐮𝐛𝐦𝐢𝐭 𝐲𝐨𝐮𝐫 𝐚𝐛𝐬𝐭𝐫𝐚𝐜𝐭 𝐍𝐎𝐖 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐨𝐟𝐟𝐢𝐜𝐢𝐚𝐥 𝐒𝐲𝐦𝐩𝐨𝐬𝐢𝐮𝐦 𝐀𝐛𝐬𝐭𝐫𝐚𝐜𝐭 𝐒𝐮𝐛𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐏𝐨𝐫𝐭𝐚𝐥 — https://art40.obsgyn.hku.hk/call-for-abstracts

Don't let this opportunity slip away! Join us as we celebrate four decades of outstanding achievements, continuous innovation, and remarkable progress within the field of assisted reproduction!

💬 Enquiries: [email protected] | +852 2376 2708

09/09/2026

📢✨ 𝐑𝐄𝐆𝐈𝐒𝐓𝐑𝐀𝐓𝐈𝐎𝐍 𝐍𝐎𝐖 | 𝐆𝐞𝐬𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐌𝐞𝐥𝐥𝐢𝐭𝐮𝐬 𝐂𝐨𝐧𝐬𝐨𝐫𝐭𝐢𝐮𝐦 & 𝐑𝐂𝐓 𝐈𝐧𝐢𝐭𝐢𝐚𝐭𝐢𝐯𝐞 𝐈𝐧𝐚𝐮𝐠𝐮𝐫𝐚𝐥 𝐀𝐬𝐢𝐚-𝐏𝐚𝐜𝐢𝐟𝐢𝐜 𝐉𝐨𝐢𝐧𝐭 𝐍𝐞𝐭𝐰𝐨𝐫𝐤 𝐖𝐨𝐫𝐤𝐬𝐡𝐨𝐩

📆 𝟏𝟑–𝟏𝟒 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟐𝟎𝟐𝟔 (𝐓𝐮𝐞𝐬𝐝𝐚𝐲 𝐚𝐧𝐝 𝐖𝐞𝐝𝐧𝐞𝐬𝐝𝐚𝐲)
📍 𝐇𝐊𝐔𝐌𝐞𝐝 𝐅𝐚𝐜𝐮𝐥𝐭𝐲 𝐁𝐨𝐚𝐫𝐝𝐫𝐨𝐨𝐦, 𝐓𝐡𝐞 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 𝐨𝐟 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠

This landmark event brings together clinician-scientists, researchers, healthcare practitioners, and cross-institutional collaborators to advance research and clinical excellence in maternal metabolic health — with a shared focus on improving care for women living with gestational diabetes mellitus (GDM).

💬 𝐊𝐞𝐲 𝐃𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧 𝐓𝐡𝐞𝐦𝐞𝐬
• Maternal Medicine & Obstetrics
• Endocrinology & Diabetes Clinical Management
• Randomised Controlled Trials
• Digital Health Technologies
• Epidemiological Research
• Allied GDM Care

Join us in Hong Kong this October as we lay the groundwork for a long-term collaborative network dedicated to improving outcomes for women with GDM and their children.

✅⏰ 𝐄𝐚𝐫𝐥𝐲-𝐁𝐢𝐫𝐝 𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐢𝐬 𝐍𝐎𝐖 𝐎𝐏𝐄𝐍!
Register on or before 15 September 2026 to enjoy a discounted rate. ⚠️ Places are limited and allocated on a first-come, first-served basis — Don't Miss Out!

📄 𝐕𝐢𝐞𝐰 𝐟𝐮𝐥𝐥 𝐩𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐞: https://gdmapac.org/programme.html
👉🏻🔗 𝐒𝐞𝐜𝐮𝐫𝐞 𝐲𝐨𝐮𝐫 𝐬𝐩𝐨𝐭 𝐍𝐎𝐖: https://gdmapac.org/registration.html

📧 Enquiries: [email protected] | ☎️ Phone: +852 2559 9973

We are excited to welcome you at this impactful knowledge sharing workshop! 🫶🏻

31/08/2026

📢 【 𝑭𝑰𝑵𝑨𝑳 𝑹𝑬𝑴𝑰𝑵𝑫𝑬𝑹 | 𝑨𝒃𝒔𝒕𝒓𝒂𝒄𝒕 𝑺𝒖𝒃𝒎𝒊𝒔𝒔𝒊𝒐𝒏 】

🕛‼️ 𝐒𝐮𝐛𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 𝐓𝐨𝐧𝐢𝐠𝐡𝐭, 𝟐𝟑:𝟓𝟗 𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠 𝐓𝐢𝐦𝐞 (𝐔𝐓𝐂/𝐆𝐌𝐓 +𝟖)

This landmark symposium, commemorating four decades of pioneering breakthroughs in assisted reproductive technology jointly fostered by The University of Hong Kong and the global reproductive medicine community, will take place from 𝟑𝟏 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝐭𝐨 𝟏 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟔 in Hong Kong.

Accepted abstracts will be featured as e-poster presentations, offering a distinguished platform to share your original research, exchange innovative insights, and connect with leading experts and peers from around the world.

📝✨ 𝐒𝐮𝐛𝐦𝐢𝐭 𝐲𝐨𝐮𝐫 𝐚𝐛𝐬𝐭𝐫𝐚𝐜𝐭 𝐍𝐎𝐖 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐨𝐟𝐟𝐢𝐜𝐢𝐚𝐥 𝐒𝐲𝐦𝐩𝐨𝐬𝐢𝐮𝐦 𝐀𝐛𝐬𝐭𝐫𝐚𝐜𝐭 𝐒𝐮𝐛𝐦𝐢𝐬𝐬𝐢𝐨𝐧 𝐏𝐨𝐫𝐭𝐚𝐥 — https://art40.obsgyn.hku.hk/call-for-abstracts 【 𝓛𝓲𝓷𝓴 𝓲𝓷 𝓑𝓲𝓸 】

Don't miss this prestigious opportunity to showcase your research at a landmark event commemorating four decades of pioneering breakthroughs in assisted reproductive technology.

💬 Enquiries: [email protected] | +852 2376 2708

19/08/2026

【最新消息】港大醫學院揭示全球高齡女性不孕症負擔持續增加 倡及早生育規劃及評估生育能力

港大醫學院臨床醫學學院婦產科學系研究團隊揭示，全球35至49歲受不孕症影響的女性人數，預計將由2023年的5,360萬人增加至2036年的7,964萬人，增幅約五成。隨着社會經濟轉型與延遲生育日趨普遍，不孕症的負擔正逐步轉向較發達經濟體，當中以東亞地區的負擔最高。研究結果為香港及全球評估不孕症負擔、制定生殖健康政策及優化資源配置提供重要科學依據，並突顯及早介入的重要性，包括及時進行生育力評估、支持生殖系統疾病的早期治療等。

東亞地區不孕症負擔居全球首位

港大醫學院研究團隊利用《全球疾病負擔研究》（Global Burden of Disease，GBD）2023年的數據，分析1990年至2023年間全球204個國家和地區35至49歲女性的不孕症情況，比較各地不孕症患病率、對健康造成的影響，並評估各地不孕症情況的改善空間，同時推算未來的趨勢變化。

研究發現，2023年全球約有5,360萬名35至49歲女性受不孕症影響，即平均每十萬名同年齡女性中約有6,900人面對不孕問題。過去33年間，全球高齡女性不孕症個案持續上升，雖然高社會人口指數（SDI）地區與低SDI地區的不孕症負擔差距較1990年收窄23.1%，但隨着社會經濟轉型和延遲生育日趨普遍，不孕症負擔正逐步由發展水平較低的地區轉向較發達經濟體。在全球21個按GBD分類的地區中，東亞地區的高齡女性不孕症負擔最高，2023年的年齡標準化患病率達每十萬人12,030宗，遠高於全球平均水平。

香港不孕防治須由治療走向預防

香港屬於東亞及高SDI地區，而遲婚、遲育情況也越趨普遍，平均生育年齡位居全球較高水平，意味著未來對生育力評估、輔導及輔助生殖服務的需求或持續增加。

研究指出，香港過往的生殖健康規劃較多集中於確診不孕症後的治療，對生育教育、風險識別、及時評估及預防措施等早期工作的重視相對不足。研究團隊認為，香港這類高度發展地區不應只着眼於治療，而應採取更主動、更具前瞻性的策略，包括加強生育力教育、推動及早生育規劃，以及促進生殖健康問題的早期識別和介入，在女性不同人生階段提供適切支援。研究同時為香港提供全球基準參考，有助評估本地生殖健康負擔、服務覆蓋情況及識別政策改善空間。

港大醫學院臨床醫學學院婦產科學系副教授李凌君教授表示：「高齡女性不孕症並非單純的臨床問題，更關乎家庭福祉、生育自主、勞動人口規劃及長遠社會發展。由於延遲生育及家庭結構轉變，不孕症的挑戰在香港日益受到關注。我們的研究提供國際基準，為香港的生殖健康資源分配提供參考，助政策制定者評估現有服務是否具備足夠的可及性、及時性及公平性，尤其是部分女性可能因經濟成本、認知不足，或工作與家庭責任衝突而延遲求診。」

李凌君教授續指，研究結果支持建立以生命歷程為基礎的生殖健康策略，包括提升生育力認知、預防及早期治療生殖系統疾病、適時轉介機制、公平獲取生育服務，以及制定更完善的政策支援女性和家庭作出適切的生育規劃和選擇。

籲及早介入 加強生育教育

團隊進一步推算，若現有趨勢持續，至2036年，全球35至49歲女性不孕症個案數目增加約一半至約7,964萬宗，而該疾病對健康和生活質素造成的影響亦會同步上升。研究結果顯示，高齡女性不孕症將成為未來全球重要的公共衞生挑戰，突顯及早評估生育能力、及早規劃生育，以及加強生殖健康服務的重要性。

李凌君教授表示：「這項研究是根據歷史數據及現有趨勢作出推算，而非對未來情況的精確預測。儘管如此，研究結果清楚顯示，高齡女性不孕症問題正持續加劇，值得社會高度關注。我們有必要採取更早期及更具針對性的公共衞生措施，以應對延遲生育為生殖健康所帶來的影響。」

研究結果已於國際醫學期刊《The Lancet Obstetrics, Gynaecology, & Women’s Health》發表：https://www.thelancet.com/journals/lanogw/article/PIIS3050-5038(26)00116-0/fulltext

(English) HKUMed reveals rising global infertility burden during advanced maternal age, advocates for early fertility planning and assessment: https://www.med.hku.hk/en/news/press/20260818-hkumed-reveals-rising-global-infertility-burden-during-advanced-maternal-age

#港大醫學院

12/08/2026

✨𝓕𝓻𝓮𝓮 𝓟𝓻𝓸𝓯𝓮𝓼𝓼𝓲𝓸𝓷𝓪𝓵 𝓞𝓷𝓵𝓲𝓷𝓮 𝓣𝓪𝓵𝓴✨

The o***y has traditionally been viewed through the lens of ovarian follicles and oocyte quality. However, emerging evidence suggests that the ovarian stroma plays a crucial role in regulating follicle development, ovarian ageing, tissue homeostasis, and reproductive lifespan.

Join us for the upcoming professional online talk featuring 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐨𝐫 𝐅𝐫𝐚𝐧𝐜𝐞𝐬𝐜𝐚 𝐄. 𝐃𝐔𝐍𝐂𝐀𝐍 and 𝐃𝐫. 𝐄𝐥𝐧𝐮𝐫 𝐁𝐀𝐁𝐀𝐘𝐄𝐕. They will discuss new insights into ovarian stromal biology and how these discoveries may open new clinical opportunities for understanding, preserving, and extending female reproductive longevity.

📢 Meeting Title: 𝐓𝐡𝐞 𝐎𝐯𝐚𝐫𝐢𝐚𝐧 𝐒𝐭𝐫𝐨𝐦𝐚 𝐚𝐬 𝐚 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐅𝐫𝐨𝐧𝐭𝐢𝐞𝐫 𝐟𝐨𝐫 𝐑𝐞𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐯𝐞 𝐋𝐨𝐧𝐠𝐞𝐯𝐢𝐭𝐲
📅 Date: 7 September 2026 (Monday)
🕕 Time: 8:00 - 9:00 p.m. (Hong Kong Time)
🖥️ Format: Online via Zoom

🔎✨ 𝐃𝐨𝐧’𝐭 𝐦𝐢𝐬𝐬 𝐭𝐡𝐢𝐬 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐭𝐨 𝐥𝐞𝐚𝐫𝐧 𝐚𝐛𝐨𝐮𝐭 𝐧𝐞𝐰 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐢𝐞𝐬 𝐢𝐧 𝐨𝐯𝐚𝐫𝐢𝐚𝐧 𝐬𝐭𝐫𝐨𝐦𝐚 𝐚𝐧𝐝 𝐟𝐞𝐦𝐚𝐥𝐞 𝐫𝐞𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐯𝐞 𝐥𝐨𝐧𝐠𝐞𝐯𝐢𝐭𝐲. — 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐍𝐎𝐖: https://forms.cloud.microsoft/r/b6JZfsbX97

07/08/2026

05/08/2026

📄 【𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐈𝐧𝐟𝐞𝐫𝐭𝐢𝐥𝐢𝐭𝐲 𝐀𝐦𝐨𝐧𝐠 𝐎𝐥𝐝𝐞𝐫 𝐖𝐨𝐦𝐞𝐧】 ✨✨

We are delighted to share the latest research findings from Professor Queenie L.J. Li’s team, published in the prestigious journal 𝑻𝒉𝒆 𝑳𝒂𝒏𝒄𝒆𝒕 𝑶𝒃𝒔𝒕𝒆𝒕𝒓𝒊𝒄𝒔, 𝑮𝒚𝒏𝒂𝒆𝒄𝒐𝒍𝒐𝒈𝒚, & 𝑾𝒐𝒎𝒆𝒏'𝒔 𝑯𝒆𝒂𝒍𝒕𝒉.

Using data from the Global Burden of Disease (GBD) 2023 study, the research team examined the impact of infertility among women aged 35–49 in 204 countries and territories over a period of 33 years (1990–2023).

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬:

• In 2023, an estimated 53.6 million women aged 35–49 worldwide were affected by infertility, with the disease burden steadily increasing over the past 30 years.

• Although the gap in infertility rates between low- and high-income regions has narrowed by 23.1% since 1990, the burden is increasingly shifting towards more developed economies.

• If current trends continue, infertility cases among older women are projected to rise by approximately 48.6% by 2036, highlighting the urgent need for proactive public health planning.

Given that the average age of childbearing in Hong Kong is among the highest globally, the research team emphasizes that local reproductive health strategies have traditionally focused on treating infertility, leaving room for improvement in fertility education, risk identification, and early assessment.

This study provides valuable international benchmarks to guide reproductive health policy and resource allocation in Hong Kong, supporting the development of a more proactive, life-course approach to women's reproductive health.

We extend our heartfelt congratulations to Professor Li and all collaborating researchers for this significant contribution to global reproductive health research!

📑 𝑹𝒆𝒂𝒅 𝒕𝒉𝒆 𝑭𝒖𝒍𝒍 𝑺𝒕𝒖𝒅𝒚: https://doi.org/10.1016/S3050-5038(26)00116-0



—
📄 【最新研究發表：高齡女性不育症全球趨勢研究】 ✨✨

我們非常高興能與大家分享李凌君教授（Professor Queenie L.J. Li）團隊的最新研究成果發表，該論文已刊於國際權威期刊《The Lancet Obstetrics, Gynaecology, & Women's Health》。

研究團隊運用《全球疾病負擔研究》（Global Burden of Disease, GBD）2023 年數據，對全球 204 個國家和地區 35 至 49 歲女性的不育症負擔，進行了長達 33 年（1990 至2023 年）的全面分析。

研究要點：

• 2023 年，全球估計有 5,360 萬名 35 至 49 歲女性受不育症困擾，過去 30 年間相關疾病負擔持續上升。

• 低收入地區與高收入地區之間的不育症差異，自 1990 年以來雖已收窄23.1%，但不孕症負擔正逐漸轉向較發達經濟體。

• 若現行趨勢持續，預計至 2036 年，高齡女性不育症病例數目將上升約48.6%，反映公共衛生政策制定實需及早規劃、積極應對。

香港女性生育年齡持續上升，平均生育年齡位居全球較高水平。研究團隊指出，本港生殖健康規劃過往較集中於治療層面，而生育教育、風險識別及早期評估仍有優化空間。

這項研究為香港的生殖健康政策規劃及資源分配，提供了寶貴的國際參考基準，有助建立更主動、貫穿女性生命歷程的整全生殖健康策略。

我們衷心祝賀李教授及所有參與本研究之學者與合作夥伴，為全球生殖健康領域研究作出的重要貢獻！

📑 完整論文連結：https://doi.org/10.1016/S3050-5038(26)00116-0

#香港大學醫學院 #婦產科學系 #生殖健康 #全球疾病負擔研究 #女性健康 #不育症 #不孕症研究 #公共衞生 #醫學研究

22/07/2026

【𝐂𝐨𝐧𝐠𝐫𝐚𝐭𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 𝐭𝐨 𝐃𝐫. 𝐃𝐨𝐫𝐨𝐭𝐡𝐲 𝐓.𝐘. 𝐂𝐇𝐀𝐍!】

🥳🎉 We are delighted to announce that 𝐃𝐫. 𝐃𝐨𝐫𝐨𝐭𝐡𝐲 𝐓.𝐘. 𝐂𝐇𝐀𝐍 has been awarded the 𝐓𝐚𝐧𝐠 𝐏𝐫𝐢𝐳𝐞 𝐟𝐨𝐫 𝟐𝟎𝟐𝟓/𝟐𝟔 𝐢𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐢𝐧 𝐎𝐛𝐬𝐭𝐞𝐭𝐫𝐢𝐜𝐬 𝐚𝐧𝐝 𝐆𝐲𝐧𝐚𝐞𝐜𝐨𝐥𝐨𝐠𝐲!

Dr. Chan’s outstanding research, titled ”𝐏𝐫𝐞𝐧𝐚𝐭𝐚𝐥 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐨𝐟 𝐭𝐰𝐢𝐧𝐬 𝐰𝐢𝐭𝐡 𝐭𝐡𝐚𝐧𝐚𝐭𝐨𝐩𝐡𝐨𝐫𝐢𝐜 𝐝𝐲𝐬𝐩𝐥𝐚𝐬𝐢𝐚 𝐭𝐲𝐩𝐞 𝐈 𝐚𝐧𝐝 𝐃𝐨𝐰𝐧 𝐬𝐲𝐧𝐝𝐫𝐨𝐦𝐞: 𝐚 𝐜𝐚𝐬𝐞 𝐫𝐞𝐩𝐨𝐫𝐭,“ demonstrates clinical insight and a commitment to advancing prenatal diagnostics in complex twin pregnancies. Her work contributes valuable knowledge to the international Obstetrics and Gynaecology community.

📚✨Established in 2010 through the generous donation of Professor Grace W.K. TANG, the Tang Prize recognizes excellence in research among trainees in our Department of Obstetrics and Gynaecology at HKU and Queen Mary Hospital. This prestigious award continues to inspire our trainees to push the boundaries of clinical research and enhance our specialty.

Dr. Chan‘s achievement exemplifies the spirit of curiosity, diligence, and clinical excellence that this prize seeks to recognise. We look forward to seeing her continued contributions to research and patient care in the years ahead. 🫶🏻

Once again, congratulations, Dr. Chan — this is a well-deserved recognition! 🥰👏🏻👏🏻